Tennessee Fungal Meningitis Cases

Outbreak of meningitis cases in Tennessee.

2012-10-21

CHATTANOOGA, TN, October 21, 2012 (Press-News.org) Another tragic health epidemic has been found in Tennessee due to the use of a contaminated steroid medication made by a Massachusetts pharmaceutical company that has been used as steroid epidural injections for a variety of medical problems, including chronic back pain.

The traditional television marketers in the legal profession have already started their glitzy campaigns soliciting victims of this tragic catastrophe that may have affected thousands who were administered this potentially bad drug.

Respected local retired physician Dr. Clif Cleveland has written an excellent summary of the issue in the Chattanooga Times Free Press on Thursday, October 18, 2012 beginning on page E-2, which should be reviewed if you have had complications after taking injections for your back or other medical problems.

The Center for Disease Control has started to publicize the problem on their website at http://www.cdc.gov/HAI/outbreaks/meningitis.html, and many medical websites such as www.emaxhealth.com have addressed it as well. As of October 17, 2012, the Tennessee Health Department (http://health.state.tn.us/) indicated that 74 healthcare facilities in Tennessee received shipments of the steroids in question.

Summers & Wyatt suggests that, if you have had steroid epidural injections or a loved one has died, you immediately: (1)contact your physician, clinic, and/or hospital to ascertain whether you received a steroid manufactured by New England Compounding Center of Framingham, Massachusetts; and (2) contact a law firm of your choice that has a reputation and proven track record of handling product liability cases in the past and not just soliciting cases by television advertising promotions.

If you have any questions concerning these issues, contact Summers & Wyatt for a free consultation as to how you should protect your interests and ascertain what steps need to be taken in this complicated area of the medical and legal system.

Website: www.summersandwyatt.com

ELSE PRESS RELEASES FROM THIS DATE:

Autoglass Celebrates Landmark Birthday and 30 Million Customers

2012-10-21

Autoglass, the UK's leading vehicle glass repair and replacement specialist, has announced it has served over 30 million customers and replaced 17 million windscreens as it celebrates 40 years of serving UK motorists. The company is celebrating its 40th birthday with the launch of a stop-motion video highlighting 40 years of automotive innovation, featuring its staff from across the UK. Matthew Mycock, Autoglass Managing Director commented: "The company and industry has undergone enormous change over the last 40 years. Our focus on innovation and customer service ...

Elephant.co.uk Reveals the Factors Affecting Car Value

2012-10-21

As well as a poor service history, lack of MOT and high mileage, motorists may be surprised to learn everyday spills and stains, dog smells and cigarette burns could affect the value of their car. New research by car insurance specialist, elephant.co.uk has revealed small steps such as taking time to thoroughly mop up spills, putting a blanket down for pets and making small repairs to the interior will help ensure motorists get maximum value when they come to sell their car. elephant.co.uk talked to its network of approved repair garages to ask what they consider ...

Shea & Shea Provides Representation to Bus Accident Victims

2012-10-21

Since 1966, the legal team from Shea & Shea has been dedicated to providing their clients with high-quality representation in all types of complex personal injury accidents. Recently, they have begun to offer their legal services to the victims of passenger bus crashes. At their firm, they recognize the dangers of riding in motor coaches with accidents being caused by everything from improper maintenance to mechanical failure, tire blowout and even driver error. As these vehicles are difficult to drive, it can be not only dangerous, but life-threatening if the driver ...

Minority obesity, perinatal health, and testicular cancer among topics for UH Rainbow doctors at AAP

2012-10-20

Combating obesity in minorities, looking at improvements in perinatal health in Ohio, and treating rare testicular cancer in adolescents are among the presentations physicians from University Hospitals (UH) Rainbow Babies & Children's Hospital will give at the American Academy of Pediatrics (AAP) 2012 National Conference in New Orleans Oct. 20 to 23. Susanna Briskin, MD, pediatric sports medicine physician at UH Rainbow Babies & Children's Hospital, will present "Overcoming Barriers to Physical Fitness in Minority Populations;" Michele Walsh, MD, Chief, Division of Neonatology, ...

Pediatric studies show the flu's deadly danger, the benefits of school vaccinations

2012-10-20

San Diego, CA (October 19, 2012) – New data being presented at IDWeek 2012TM shows the fatal risk that influenza poses even for children without underlying health conditions and the effectiveness of school-based vaccination programs in protecting student populations. Together, these findings support the crucial public health message that families should take the flu virus seriously every year. One study viewed influenza from an epidemiological perspective, analyzing U.S. pediatric influenza-associated deaths over an eight-year period and finding that 43 percent of the ...

Women more likely to die from myocardial infarction than men

2012-10-20

Istanbul, Turkey – 20 October 2012: Women are more likely to die from a myocardial infarction than men, according to research presented at the Acute Cardiac Care Congress 2012. The gender gap in mortality was independent of patient characteristics, revascularisation delays and revascularisation modalities. Women also had longer treatment delays, less aggressive treatment, more complications and longer hospital stays. The study was presented by Dr Guillaume Leurent from the Centre Hospitalier Universitaire in Rennes, France. The Acute Cardiac Care Congress 2012 is the ...

Calling an ambulance improves heart attack survival

2012-10-20

Istanbul, Turkey – 20 October 2012: The Acute Cardiac Care Congress 2012 is the first annual meeting of the newly launched Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC). It takes place from 20 to 22 October in Istanbul, Turkey, at the Istanbul Lufti Kirdar Convention and Exhibition Centre (ICEC). Primary percutaneous coronary intervention (pPCI), also called balloon treatment, opens the coronary vessel and is preferred over intravenous (IV) medicine (called thrombolysis) to dissolve blood clots in patients with heart attacks. ...

Coronary angioplasty improves cardiac arrest survival

2012-10-20

Istanbul, Turkey – 20 October 2012: Coronary angioplasty improves survival in all patients with out of hospital cardiac arrest, according to research presented at the Acute Cardiac Care Congress 2012. The study was presented by Dr Annamaria Nicolino from the Santa Corona General Hospital in Pietra Ligure, Italy. The Acute Cardiac Care Congress 2012 is the first annual meeting of the newly launched Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC). It takes place during 20-22 October in Istanbul, Turkey, at the Istanbul Lufti Kirdar ...

Using human stool to treat C. diff is safe, effective

2012-10-20

DETROIT – A novel therapy that uses donated human stool to treat the deadly and contagious C.diff infection is safe and highly effective, according to a Henry Ford Hospital study. Researchers found that 43 of 49 patients recovered swiftly after treatment and had no adverse complications from C.diff three months later. Treatment is performed either through a nasogastric tube or colonscopy on an outpatient or inpatient basis. Mayur Ramesh, M.D., a Henry Ford Infectious Diseases physician and senior author of the study, says the treatment, while appearing unconventional, ...

Study: Optimal treatment duration for MRSA-related pneumonia

2012-10-20

DETROIT – The national practice guideline for treating MRSA-related pneumonia is seven to 21 days. A Henry Ford Hospital study found that effective treatment can be done in half the time. Researchers found that 40 percent of patients were treated for eight to 13 days on a therapy of the antibiotics vancomycin or linezolid, and had the highest survival rate. The Henry Ford study is believed to be the first to evaluate the length of treatment for MRSA-related pneumonia. The study is being presented Friday at the annual Infectious Diseases Society of America meeting ...

Tennessee Fungal Meningitis Cases

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: